Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Adenocarcinoma, Follicular × Trastuzumab × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 101 Stomach Neoplasms 17 HER2-positive Breast Cancer 13 Neoplasms 11 Neoplasm Metastasis 9 Colorectal Neoplasms 9 Esophageal Neoplasms 7 Triple Negative Breast Neoplasms 4 Meningeal Neoplasms 4 Colonic Neoplasms 4 Brain Neoplasms 4 Adenocarcinoma Of Esophagus 4 Salivary Gland Neoplasms 3 Rectal Neoplasms 3 Meningeal Carcinomatosis 3 Lymphoma, Non-Hodgkin 3 Lung Neoplasms 3 Gallbladder Neoplasms 3 Endometrial Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Biliary Tract Neoplasms 3 Anatomic Stage I Breast Cancer AJCC v8 3 Solid Tumors 2 Prostatic Neoplasms 2 Pathologic Complete Response 2 Ovarian Neoplasms 2 Multiple Myeloma 2 Inflammatory Breast Neoplasms 2 Hematologic Neoplasms 2 HER2-positive Gastric Cancer 2

Interventions

X-Rays 3 Magnetic Resonance Spectroscopy 3 Specimen Handling 2 tremelimumab 1 trametinib 1 spartalizumab 1 pembrolizumab 1 lenvatinib 1 gallium Ga 68 dotatate 1 durvalumab 1 dabrafenib 1 cobimetinib 1 cabozantinib 1 Vemurafenib 1 Thyrotropin Alfa 1 Sunitinib 1 Photons 1 Pharmacogenomic Testing 1 Phantoms, Imaging 1 Iodine-131 1 Iodine-123 1 High-Energy Shock Waves 1 Glycoprotein Hormones, alpha Subunit 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡